LS-P-RACES(JP04)

Protocol Addendum J1S-MC-JP04 A Randomized, Open-Label, Phase 2 Study Evaluating Abemaciclib in Combination with Irinotecan and Temozolomide in Participants with Relapsed or Refractory Ewing’s Sarcoma.